TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Sep 2023

Income Metrics

Revenue 118.4M
Gross Profit 68.4M 57.77%
Operating Income 13.0M 11.02%
Net Income 8.2M 6.92%
EPS (Diluted) $0.08

Balance Sheet Metrics

Total Assets 498.6M
Total Liabilities 460.1M
Shareholders Equity 38.5M
Debt to Equity 11.96

Cash Flow Metrics

Operating Cash Flow 35.6M
Free Cash Flow 39.7M

Revenue & Profitability Trend

Procaps Group S.A Income Statement From 2019 to 2022

Metric2022202120202019
Revenue i409.9M409.7M331.5M324.8M
Cost of Goods Sold i170.4M174.0M140.2M142.3M
Gross Profit i239.6M235.7M191.3M182.5M
Gross Margin % i58.4%57.5%57.7%56.2%
Operating Expenses
Research & Development i----
Selling, General & Administrative i199.5M165.2M128.3M145.1M
Other Operating Expenses i----
Total Operating Expenses i199.5M165.2M128.3M145.1M
Operating Income i39.0M69.7M61.6M36.0M
Operating Margin % i9.5%17.0%18.6%11.1%
Non-Operating Items
Interest Income i----
Interest Expense i25.8M85.3M52.6M41.5M
Other Non-Operating Income49.8M-67.9M-6.3M-3.0M
Pre-tax Income i52.7M-87.2M849.0K-10.0M
Income Tax i10.2M13.7M11.3M7.0M
Effective Tax Rate % i19.3%0.0%1,330.5%0.0%
Net Income i42.5M-100.9M-10.4M-17.0M
Net Margin % i10.4%-24.6%-3.2%-5.2%
Key Metrics
EBITDA i44.6M8.3M74.7M50.7M
EPS (Basic) i$0.42$-1.03$-0.11$-0.17
EPS (Diluted) i$0.42$-1.03$-0.11$-0.17
Basic Shares Outstanding i101110000981430009762500097625000
Diluted Shares Outstanding i101110000981430009762500097625000

Income Statement Trend

Procaps Group S.A Balance Sheet From 2019 to 2022

Metric2022202120202019
Assets
Current Assets
Cash & Equivalents i43.0M72.1M4.2M2.0M
Short-term Investments i----
Accounts Receivable i114.4M101.0M86.2M96.5M
Inventory i96.8M79.4M64.3M65.0M
Other Current Assets4.3M5.8M360.0K98.0K
Total Current Assets i297.4M298.1M184.7M172.4M
Non-Current Assets
Property, Plant & Equipment i73.7M73.8M78.2M74.1M
Goodwill i43.8M43.8M41.3M37.2M
Intangible Assets i32.2M30.2M27.6M23.2M
Long-term Investments----
Other Non-Current Assets10.1M11.6M23.6M19.3M
Total Non-Current Assets i162.7M164.1M174.8M165.3M
Total Assets i460.2M462.1M359.5M337.7M
Liabilities
Current Liabilities
Accounts Payable i81.5M70.2M84.5M94.2M
Short-term Debt i257.5M74.6M114.8M100.0M
Current Portion of Long-term Debt----
Other Current Liabilities11.5M7.2M11.1M9.0M
Total Current Liabilities i368.4M188.0M239.6M248.5M
Non-Current Liabilities
Long-term Debt i28.4M178.7M339.7M320.5M
Deferred Tax Liabilities i7.8M6.1M18.9M7.7M
Other Non-Current Liabilities46.5M104.6M3.8M5.1M
Total Non-Current Liabilities i93.7M312.5M374.6M333.2M
Total Liabilities i462.1M500.5M614.2M581.7M
Equity
Common Stock i1.0M1.0M2.0M2.0M
Retained Earnings i-391.5M-431.1M-327.3M-305.6M
Treasury Stock i----
Other Equity----
Total Shareholders Equity i-1.9M-38.3M-254.7M-243.9M
Key Metrics
Total Debt i285.9M253.4M454.5M420.4M
Working Capital i-70.9M110.1M-54.9M-76.0M

Balance Sheet Composition

Procaps Group S.A Cash Flow Statement From 2019 to 2022

Metric2022202120202019
Operating Activities
Net Income i42.5M-100.9M-10.4M-17.0M
Depreciation & Amortization i16.8M15.1M16.5M16.5M
Stock-Based Compensation i----
Working Capital Changes i-21.0M-33.5M5.3M36.2M
Operating Cash Flow i10.6M47.0M77.1M85.7M
Investing Activities
Capital Expenditures i-17.9M-13.3M-7.1M-11.5M
Acquisitions i----
Investment Purchases i----
Investment Sales i----
Investing Cash Flow i-17.9M-13.3M-6.9M-11.5M
Financing Activities
Share Repurchases i0-45.0M00
Dividends Paid i0000
Debt Issuance i134.4M280.8M106.7M96.4M
Debt Repayment i-130.9M-281.2M-126.3M-122.5M
Financing Cash Flow i-3.6M75.5M-25.4M-30.7M
Free Cash Flow i-17.5M12.8M53.0M48.6M
Net Change in Cash i-10.8M109.2M44.8M43.5M

Cash Flow Trend

Procaps Group S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 1.53
Forward P/E 3.74
Price to Book 3.04
Price to Sales 0.31
PEG Ratio -0.02

Profitability Ratios

Profit Margin 58.44%
Operating Margin 19.14%
Return on Equity -2,265.18%
Return on Assets 9.24%

Financial Health

Current Ratio 1.47
Debt to Equity 7.54

Per Share Data

EPS (TTM) $0.42
Book Value per Share $0.38
Revenue per Share $4.05

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
proc128.6M1.533.04-2,265.18%58.44%7.54
Haleon Plc - ADR 41.7B19.935.089.38%13.81%53.41
United Therapeutics 19.3B16.922.6819.30%40.36%0.00
Ironwood 230.7M92.69-0.73-0.29%-2.56%-1.94
BioAge Labs 212.2M-0.890.72-35.88%0.00%2.97
Journey Medical 186.8M39.088.66-57.22%-15.49%131.34

Financial data is updated regularly. All figures are in the company's reporting currency.